HomeCompareSMTSF vs JNJ

SMTSF vs JNJ: Dividend Comparison 2026

SMTSF yields 240.82% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMTSF wins by $364.50M in total portfolio value
10 years
SMTSF
SMTSF
● Live price
240.82%
Share price
$0.83
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$364.53M
Annual income
$200,641,670.96
Full SMTSF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SMTSF vs JNJ

📍 SMTSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMTSFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMTSF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMTSF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMTSF
Annual income on $10K today (after 15% tax)
$20,470.09/yr
After 10yr DRIP, annual income (after tax)
$170,545,420.32/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SMTSF beats the other by $170,541,434.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMTSF + JNJ for your $10,000?

SMTSF: 50%JNJ: 50%
100% JNJ50/50100% SMTSF
Portfolio after 10yr
$182.28M
Annual income
$100,323,180.18/yr
Blended yield
55.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SMTSF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
0.8
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMTSF buys
0
JNJ buys
0
No recent congressional trades found for SMTSF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMTSFJNJ
Forward yield240.82%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$364.53M$30.3K
Annual income after 10y$200,641,670.96$4,689.40
Total dividends collected$346.80M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SMTSF vs JNJ ($10,000, DRIP)

YearSMTSF PortfolioSMTSF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$34,782$24,082.46$10,592$272.30+$24.2KSMTSF
2$115,502$78,284.78$11,289$357.73+$104.2KSMTSF
3$366,540$242,953.29$12,123$472.89+$354.4KSMTSF
4$1,112,760$720,562.04$13,141$629.86+$1.10MSMTSF
5$3,235,060$2,044,406.89$14,408$846.81+$3.22MSMTSF
6$9,016,262$5,554,747.56$16,021$1,151.60+$9.00MSMTSF
7$24,115,940$14,468,539.20$18,122$1,588.22+$24.10MSMTSF
8$61,971,562$36,167,506.18$20,930$2,228.20+$61.95MSMTSF
9$153,170,213$86,860,642.40$24,792$3,191.91+$153.15MSMTSF
10$364,533,799$200,641,670.96$30,274$4,689.40+$364.50MSMTSF

SMTSF vs JNJ: Complete Analysis 2026

SMTSFStock

Sierra Metals Inc., together with its subsidiaries, focuses on the production, exploration, and development of precious and base metals in Peru and Mexico. It primarily focuses on exploration of silver, copper, lead, zinc, and gold deposits. The company's flagship property is the 81.84% owned polymetallic Yauricocha Mine covering an area of 18,778 hectares located in the Yauyos province in Peru. It also holds 100% interest in the Bolivar mine, comprising of 12 mining concessions covering an area 15,217 hectares; and Cusi Mines that comprises of 73 concessions covering 11,977 hectares in Mexico. The company was formerly known as Dia Bras Exploration Inc. and changed its name to Sierra Metals Inc. in December 2012. Sierra Metals Inc. was incorporated in 1996 and is headquartered in Toronto, Canada.

Full SMTSF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SMTSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMTSF vs SCHDSMTSF vs JEPISMTSF vs OSMTSF vs KOSMTSF vs MAINSMTSF vs ABBVSMTSF vs MRKSMTSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.